SeaSpine (SPNE) Given Daily News Sentiment Score of 0.11

Headlines about SeaSpine (NASDAQ:SPNE) have trended somewhat positive on Monday, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. SeaSpine earned a news impact score of 0.11 on Accern’s scale. Accern also gave news articles about the medical equipment provider an impact score of 47.0447879099988 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

A number of research analysts have recently issued reports on SPNE shares. Zacks Investment Research lowered SeaSpine from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Ladenburg Thalmann Financial Services assumed coverage on SeaSpine in a research note on Thursday, December 14th. They issued a “buy” rating and a $20.00 price objective for the company. BTIG Research reissued a “buy” rating and issued a $17.00 price objective on shares of SeaSpine in a research note on Friday, March 2nd. Finally, HC Wainwright set a $15.00 price objective on SeaSpine and gave the company a “buy” rating in a research note on Friday, March 2nd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and four have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $17.20.

How to Become a New Pot Stock Millionaire

SeaSpine stock traded down $0.02 during midday trading on Monday, reaching $9.95. The company had a trading volume of 3,467 shares, compared to its average volume of 36,701. SeaSpine has a 1 year low of $6.87 and a 1 year high of $13.46. The firm has a market cap of $144.94, a P/E ratio of -3.81 and a beta of 0.36.

SeaSpine (NASDAQ:SPNE) last posted its quarterly earnings data on Wednesday, February 28th. The medical equipment provider reported ($0.56) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.52) by ($0.04). SeaSpine had a negative net margin of 24.36% and a negative return on equity of 29.96%. The firm had revenue of $33.98 million during the quarter. equities analysts predict that SeaSpine will post -1.99 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “SeaSpine (SPNE) Given Daily News Sentiment Score of 0.11” was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3278775/seaspine-spne-given-daily-news-sentiment-score-of-0-11.html.

SeaSpine Company Profile

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.

Insider Buying and Selling by Quarter for SeaSpine (NASDAQ:SPNE)

Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Consolidated Communications  & Its Competitors Financial Analysis
Consolidated Communications & Its Competitors Financial Analysis
Head to Head Analysis: Stratus Properties  & City Developments
Head to Head Analysis: Stratus Properties & City Developments
Wi Coin  Price Hits $0.0013 on Top Exchanges
Wi Coin Price Hits $0.0013 on Top Exchanges
Nasdaq  Upgraded to “Hold” at Bank of America
Nasdaq Upgraded to “Hold” at Bank of America
Cube  Price Hits $0.0142 on Top Exchanges
Cube Price Hits $0.0142 on Top Exchanges
AMERISAFE  Rating Reiterated by Boenning Scattergood
AMERISAFE Rating Reiterated by Boenning Scattergood


© 2006-2018 Ticker Report. Google+.